Cipla to be listed in Dow Jones Sustainability Index for emerging markets Ruchika Sharma16 Nov 2021 12:00 PM ISTMumbai: Cipla Limited has recently announced that the company has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging...
Cipla resolves funding dispute with Pulmatrix over asthma drug Pumazole Ruchika Sharma12 Nov 2021 1:31 PM ISTPulmazole is an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
Cipla unit gets termination notice on Rs 1560 crore acquisition deal with Avenue Therapeutics Hina Zahid5 Nov 2021 6:11 PM ISTIn November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US based speciality business...
Indian Pharma Market sees 13 percent growth in September sales: AIOCD-AWACS Report Medical Dialogues Team21 Oct 2021 5:51 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant growth of 13% at Total Sales Audit (TSA) and 11% at Secondary Sales...
After selling Humalog, Trulicity rights to Cipla, Eli Lilly sacks 120 staff in India: Report Medical Dialogues Team11 Oct 2021 5:46 PM ISTNew Delhi: After transferring the rights to sell popular anti-diabetes drugs Humalog and Trulicity to Mumbai-based Cipla, Eli Lilly, a global...
Eli Lilly, Cipla ink pact for Humalog,Trulicity to treat diabetes Ruchika Sharma4 Oct 2021 2:05 PM ISTNew Delhi: Eli Lilly and Company (India) Pvt. Ltd., is a wholly owned subsidiary of Eli Lilly and Company, a global biopharmaceutical...
Cipla eyes acquisitions after Covid windfall: Bloomberg Ruchika Sharma2 Oct 2021 9:30 AM ISTNew Delhi: Cipla Ltd., one of India's largest drugmakers, has built up a war chest and is on the prowl for deals that can boost growth beyond the...
NPPA fixes retail price of 23 formulations; details Medical Dialogues Team27 Sept 2021 4:37 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
India to not buy Pfizer, Moderna Covid-19 vaccines: Report Ruchika Sharma23 Sept 2021 12:30 PM ISTNew Delhi: India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because...
NPPA authority rejects Cipla's plea to discontinue four HIV drugs including Abamune, Efavir Medical Dialogues Team14 Sept 2021 2:51 PM ISTNew Delhi: Considering the major public interest, the National Pharmaceutical Pricing Authority (NPPA) has rejected Cipla's application to discontinue...
37 drug samples including Cipla Acivir-200DT fail to clear CDSCO test, 1 declared misbranded Medical Dialogues Team11 Sept 2021 12:24 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), flagged 37...
Cipla seeks price hike of asthma drugs citing 300 percent rise in production cost, writes to NPPA Medical Dialogues Team8 Sept 2021 3:01 PM ISTNew Delhi: Citing a 300 percent rise in the price of propellant P227, a critical ingredient used in respiratory formulation, Cipla has written to the...
